Market Place
Sourcing Support
All News #Library
Biotech
Instil`s Stock Sinks After It Clears Out Clinical Pipeline
06 Jan 2026 //
GLOBENEWSWIRE
Instil Bio Reveals `2510 Monotherapy Data for 2L+ Squamous NSCLC
10 Sep 2025 //
GLOBENEWSWIRE
Instil Bio`s Q2 2025 Financial Results and Corporate Update
13 Aug 2025 //
GLOBENEWSWIRE
Instil`s PD-L1xVEGF Bispecific Shows Promise in China
31 Jul 2025 //
FIERCE BIOTECH
Instil Bio & ImmuneOnco to Host Investor Breakfast at 2025 ASCO
23 May 2025 //
GLOBENEWSWIRE
Instil, ImmuneOnco’s NSCLC Trial on Track for Q3 2025 Completion
22 May 2025 //
GLOBENEWSWIRE
Instil Bio Reports China Progress For PD-L1xVEGF Antibody IMM2510
14 Jan 2025 //
GLOBENEWSWIRE
Instil Bio Reports Q3 2024 Financial Results & Corporate Update
13 Nov 2024 //
GLOBENEWSWIRE
Instil Bio And ImmuneOnco Announce PD-L1xVEGF Strategy
16 Sep 2024 //
GLOBENEWSWIRE
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC
06 Nov 2023 //
GLOBENEWSWIRE
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data
26 Jun 2023 //
GLOBENEWSWIRE
Instil Bio Announces Resumption of Trial of CoStAR-TIL Candidate ITIL-306
09 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.